Age-related Macular Degeneration

Showing NaN - NaN of 15

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Age-related Macular Degeneration Trial in Boston (Omega-3 fatty acids (fish oil), Vitamin D3, Vitamin D3 )

Active, not recruiting
  • Age-related Macular Degeneration
  • Omega-3 fatty acids (fish oil)
  • +3 more
  • Boston, Massachusetts
    Brigham and Women's Hospital
Jul 26, 2022

Age-related Macular Degeneration Trial in Boston (Atorvastatin 80mg)

Recruiting
  • Age-related Macular Degeneration
  • Atorvastatin 80mg
  • Boston, Massachusetts
    Massachusetts Eye and Ear Infirmary
Oct 7, 2021

Global Atrophie Biomarker Evaluation Study (GABiE)

Terminated
  • Age-related Macular Degeneration
  • Diagnostics
  • Boston, Massachusetts
  • +1 more
Apr 29, 2021

Geographic Atrophy, Age-related Macular Degeneration Trial in United States (LFG316, Sham, LFG316 Lower dose)

Completed
  • Geographic Atrophy
  • Age-related Macular Degeneration
  • Phoenix, Arizona
  • +18 more
Dec 9, 2020

Sub-retinal Transplantation of hESC Derived RPE Cells in AMD

Completed
  • Age-Related Macular Degeneration
  • MA09-hRPE
  • Los Angeles, California
  • +3 more
Nov 10, 2020

Age-Related Macular Degeneration Trial in Worldwide (E10030, bevacizumab or aflibercept, E10030 sham injection)

Terminated
  • Age-Related Macular Degeneration
  • Gilbert, Arizona
  • +206 more
Sep 29, 2020

Choroidal Neovascularization, Age-related Macular Degeneration Trial in United States (hI-con1, ranibizumab, Sham injection)

Completed
  • Choroidal Neovascularization
  • Age-related Macular Degeneration
  • hI-con1
  • +2 more
  • Phoenix, Arizona
  • +47 more
Sep 23, 2020

Age-Related Macular Degeneration Trial in United States (Fovista®, bevacizumab, ranibizumab)

Terminated
  • Age-Related Macular Degeneration
  • Phoenix, Arizona
  • +23 more
Feb 8, 2019

Age-Related Macular Degeneration Trial in Worldwide (E10030, ranibizumab, E10030 sham intravitreal injection)

Terminated
  • Age-Related Macular Degeneration
  • Phoenix, Arizona
  • +114 more
Aug 8, 2018

Age-Related Macular Degeneration Trial in United States (Intravitreal aflibercept injection, Placebo)

Unknown status
  • Age-Related Macular Degeneration
  • Intravitreal aflibercept injection
  • Placebo
  • Beverly Hills, California
  • +3 more
Mar 29, 2016

Diabetic Macular Edema, Age-related Macular Degeneration Trial in Boston (MTP-131)

Completed
  • Diabetic Macular Edema
  • Age-related Macular Degeneration
  • Boston, Massachusetts
    (unnamed)
Oct 2, 2015

Seven Year Update of Macular Degeneration Patients

Completed
  • Age-related Macular Degeneration
    • Beverly Hills, California
    • +11 more
    Nov 12, 2013

    Age-related Macular Degeneration Trial in United States (Ranibizumab)

    Completed
    • Age-related Macular Degeneration
    • Phoenix, Arizona
    • +98 more
    Dec 11, 2012

    Age-Related Macular Degeneration Trial in Boston (Palomid 529)

    Completed
    • Age-Related Macular Degeneration
    • Palomid 529
    • Boston, Massachusetts
      Ophthalmic Consultants of Boston
    Sep 20, 2012

    Age-Related Macular Degeneration Trial in Worldwide (AG-013,958)

    Terminated
    • Age-Related Macular Degeneration
    • Mesa, Arizona
    • +38 more
    May 26, 2011